Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Frey

Showing results (111-120 of 282) with videos related to

Pageof 29
Sort By:
Blood|October 18, 2002
Expression of rat complement control protein Crry on tumor cells inhibits rat natural killer cell-mediated cytotoxicityTheresa A Caragine, Masaki Imai, Alan B Frey, et al.
Transplantation Proceedings|March 20, 1999
Value of sequential big endothelin plasma concentrations to predict rapid worsening of chronic heart failureB Stanek, B Frey, R Berger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 29, 2000
Mice bearing late-stage tumors have normal functional systemic T cell responses in vitro and in vivoS Radoja, T D Rao, D Hillman, et al.
Experimental Nephrology|January 25, 2000
Proinflammatory effects in experimental mesangial proliferative glomerulonephritis of the immunosuppressive agent SDZ RAD, a rapamycin derivativeC Daniel, R Ziswiler, B Frey, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|June 11, 2009
Twenty or thirty microgram ethinyloestradiol in an oral contraceptive: does it make a difference in the mind and the daily practise of gynaecologists and general practitioners?J Bitzer, B Frey, M von Schönau, et al.
Cell Death & Disease|May 15, 2015
Modulation of radiochemoimmunotherapy-induced B16 melanoma cell death by the pan-caspase inhibitor zVAD-fmk induces anti-tumor immunity in a HMGB1-, nucleotide- and T-cell-dependent mannerN Werthmöller, B Frey, R Wunderlich, et al.
Biochemistry|August 20, 2016
EF5 Is the High-Affinity Mg(2+) Site in ALG-2John J Tanner, Benjamin B Frey, Travis Pemberton, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1995
Apparent split tolerance of CD8+ T cells from beta 2-microglobulin-deficient (beta 2m-/-) mice to syngeneic beta 2m+/+ cellsK G Jhaver, T D Rao, A B Frey, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 9, 2005
Defective proximal TCR signaling inhibits CD8+ tumor-infiltrating lymphocyte lytic functionMythili Koneru, David Schaer, Ngozi Monu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 4, 2006
Defective adhesion in tumor infiltrating CD8+ T cellsMythili Koneru, Ngozi Monu, David Schaer, et al.
Pageof 29

Showing results (111-120 of 282) with videos related to

Sort By:
Pageof 29
Blood|October 18, 2002
Expression of rat complement control protein Crry on tumor cells inhibits rat natural killer cell-mediated cytotoxicityTheresa A Caragine, Masaki Imai, Alan B Frey, et al.
Transplantation Proceedings|March 20, 1999
Value of sequential big endothelin plasma concentrations to predict rapid worsening of chronic heart failureB Stanek, B Frey, R Berger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 29, 2000
Mice bearing late-stage tumors have normal functional systemic T cell responses in vitro and in vivoS Radoja, T D Rao, D Hillman, et al.
Experimental Nephrology|January 25, 2000
Proinflammatory effects in experimental mesangial proliferative glomerulonephritis of the immunosuppressive agent SDZ RAD, a rapamycin derivativeC Daniel, R Ziswiler, B Frey, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|June 11, 2009
Twenty or thirty microgram ethinyloestradiol in an oral contraceptive: does it make a difference in the mind and the daily practise of gynaecologists and general practitioners?J Bitzer, B Frey, M von Schönau, et al.
Cell Death & Disease|May 15, 2015
Modulation of radiochemoimmunotherapy-induced B16 melanoma cell death by the pan-caspase inhibitor zVAD-fmk induces anti-tumor immunity in a HMGB1-, nucleotide- and T-cell-dependent mannerN Werthmöller, B Frey, R Wunderlich, et al.
Biochemistry|August 20, 2016
EF5 Is the High-Affinity Mg(2+) Site in ALG-2John J Tanner, Benjamin B Frey, Travis Pemberton, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1995
Apparent split tolerance of CD8+ T cells from beta 2-microglobulin-deficient (beta 2m-/-) mice to syngeneic beta 2m+/+ cellsK G Jhaver, T D Rao, A B Frey, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 9, 2005
Defective proximal TCR signaling inhibits CD8+ tumor-infiltrating lymphocyte lytic functionMythili Koneru, David Schaer, Ngozi Monu, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 4, 2006
Defective adhesion in tumor infiltrating CD8+ T cellsMythili Koneru, Ngozi Monu, David Schaer, et al.
Pageof 29